P356 Long-term outcome of UC patients in clinical remission with different level of mucosal activity: real world, retrospective, multicontinental study

P Bacsur,P Wetwittayakhlang,T Resál,B Farkas,M Rutka,T Bessissow,W Afif,A Bálint,A Fábián,R Bor,Z Szepes,K Farkas,P L Lakatos,T Molnár

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0486

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background In contrast to the increasingly rigorous endpoints of clinical trials of ulcerative colitis (UC), Mayo endoscopic score (MES) ≤ 1 is mostly set as target during clinical follow-up, but long-term outcomes may differ according to different level of healing. Therefore, our study aimed to compare the long-term outcomes of UC patients in clinical remission with different MES and UCEIS scores in real-life condition. Methods UC patients in clinical remission (defined by pMayo<2 with no rectal bleeding) who underwent colonoscopy between 2016-2020 were consecutively enrolled in this multicenter retrospective study. Mayo and UCEIS endoscopic scores were evaluated and clinical and demographic data were collected at baseline. Clinical flare, colectomy, hospitalization and treatment modifications were recorded during at least 3 year of follow-up. Primary outcome was the clinical flare, while secondary outcomes were hospitalization, colectomy, new biological initiation and biological dose escalation during follow-up. Outcomes were compared with Log-rank test and survival characteristics were plotted. Results In total, 156 UC patients were enrolled with a median age of 46.0 (IQR 35.5-58.0), while male/female ratio was 49.4 % (Table 1.). Near to half of the patients (44.9%) had MES>0 endoscopic activity at baseline. Non zero baseline MES (Figure 1.; p = 0.002; MES 0 vs 1 p = 0.004) and UCEIS (p < 0.001; UCEIS 0 vs. 1 p = 0.016) scores were associated with higher rate of clinical flare. Higher baseline MES (p = 0.042) and UCEIS (p = 0.008) scores were coupled with increased risk of hospitalization. Colectomy rates were low. Increased baseline UCEIS (p = 0.003), but not MES score was coupled with new biological treatment initiation, while only UCEIS score was associated with biological treatment intensification (>4; p = 0.008). Conclusion Our study suggests differentiating between complete MH from MES 1 as long-term outcomes were more favorable in case of lower endoscopic scores. Consequently, targeting complete MH should be considered to achieve deep remission and disease clearance.

gastroenterology & hepatology

What problem does this paper attempt to address?

This paper aims to explore the long - term prognostic differences in ulcerative colitis (UC) patients at different mucosal activity levels during clinical remission. Specifically, the researchers hope to compare the long - term prognoses of UC patients during clinical remission (defined as a pMayo score < 2 and no rectal bleeding) with different Mayo Endoscopic Scores (MES) and UC Endoscopic Severity Indexes (UCEIS) under actual clinical conditions. This includes evaluating the incidences of clinical recurrence, hospitalization, colectomy, and treatment adjustment, thereby providing a more accurate basis for target - setting in clinical practice, especially regarding whether complete mucosal healing (MES 0) should be pursued rather than partial healing (MES 1).

The research background indicates that although the treatment endpoints for UC in clinical trials are becoming increasingly strict, in clinical follow - up, MES ≤ 1 is usually targeted. However, different levels of mucosal healing may affect the long - term prognosis of patients. Therefore, this multi - center, retrospective study assesses the impact of different levels of mucosal activity on the prognosis of UC patients by analyzing long - term patient data.